D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 90 Citations 23,731 177 World Ranking 174 National Ranking 87

Overview

What is he best known for?

The fields of study he is best known for:

  • Microbiology
  • Antibiotics
  • Internal medicine

Shawn A. Messer focuses on Microbiology, Fluconazole, Candida albicans, Corpus albicans and Voriconazole. His Caspofungin, Amphotericin B, Anidulafungin, Fungi imperfecti and Itraconazole investigations are all subjects of Microbiology research. Shawn A. Messer works mostly in the field of Anidulafungin, limiting it down to topics relating to Echinocandin and, in certain cases, Echinocandins.

The Fluconazole study combines topics in areas such as Broth microdilution, Candida glabrata and Etest. As a part of the same scientific family, Shawn A. Messer mostly works in the field of Candida glabrata, focusing on Candida tropicalis and, on occasion, Candida parapsilosis. His Candida albicans study combines topics from a wide range of disciplines, such as Fungemia and Drug resistance.

His most cited work include:

  • Attributable Mortality of Nosocomial Candidemia, Revisited (948 citations)
  • International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. (479 citations)
  • Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations (479 citations)

What are the main themes of his work throughout his whole career to date?

Microbiology, Fluconazole, Voriconazole, Candida albicans and Broth microdilution are his primary areas of study. His Microbiology study focuses mostly on Caspofungin, Amphotericin B, Candida glabrata, Anidulafungin and Posaconazole. Shawn A. Messer combines subjects such as Candida parapsilosis and Candida krusei, Candida tropicalis with his study of Candida glabrata.

He has researched Fluconazole in several fields, including Itraconazole, Cryptococcus neoformans, Fungi imperfecti, Mycosis and Drug resistance. His study in the field of Ravuconazole also crosses realms of Triazole. His biological study spans a wide range of topics, including Internal medicine and Fungemia.

He most often published in these fields:

  • Microbiology (88.48%)
  • Fluconazole (49.74%)
  • Voriconazole (30.89%)

What were the highlights of his more recent work (between 2012-2021)?

  • Microbiology (88.48%)
  • Candida glabrata (21.99%)
  • Caspofungin (27.23%)

In recent papers he was focusing on the following fields of study:

His main research concerns Microbiology, Candida glabrata, Caspofungin, Anidulafungin and Echinocandin. His work is connected to Candida tropicalis, Fluconazole, Voriconazole, Broth microdilution and Aspergillus, as a part of Microbiology. His work deals with themes such as Amphotericin B, Sentry and Cryptococcus neoformans, which intersect with Fluconazole.

His work on Posaconazole as part of general Voriconazole study is frequently linked to Triazole derivatives and Triazole, therefore connecting diverse disciplines of science. His Anidulafungin study is concerned with the field of Micafungin as a whole. His work carried out in the field of Echinocandin brings together such families of science as Long acting and Echinocandins.

Between 2012 and 2021, his most popular works were:

  • Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations (479 citations)
  • Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance (168 citations)
  • Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013). (75 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Internal medicine
  • Microbiology

The scientist’s investigation covers issues in Microbiology, Candida glabrata, Caspofungin, Candida tropicalis and Anidulafungin. His study in Microbiology concentrates on Candida parapsilosis, Candida krusei, Micafungin, Candida albicans and Broth microdilution. His Candida albicans research includes elements of Isavuconazonium and Posaconazole.

Candida glabrata is frequently linked to Fluconazole in his study. Shawn A. Messer has included themes like Itraconazole, Azole and Cryptococcus neoformans in his Fluconazole study. Shawn A. Messer works mostly in the field of Caspofungin, limiting it down to topics relating to Aspergillus fumigatus and, in certain cases, Aspergillus niger, Aspergillus flavus, Aspergillus terreus, Aspergillus and Amphotericin B, as a part of the same area of interest.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Attributable Mortality of Nosocomial Candidemia, Revisited

Olafur Gudlaugsson;Olafur Gudlaugsson;Shane Gillespie;Kathleen Lee;Jeff Vande Berg.
Clinical Infectious Diseases (2003)

1341 Citations

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader.
Journal of Clinical Microbiology (2001)

763 Citations

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Barbara D. Alexander;Melissa D. Johnson;Christopher D. Pfeiffer;Cristina Jiménez-Ortigosa.
Clinical Infectious Diseases (2013)

743 Citations

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Sandra S. Richter;Rudolph P. Galask;Shawn A. Messer;Richard J. Hollis.
Journal of Clinical Microbiology (2005)

635 Citations

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Michael A Pfaller;Ronald N Jones;Shawn A Messer;Michael B Edmond.
Diagnostic Microbiology and Infectious Disease (1998)

618 Citations

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.

M. A. Pfaller;S. A. Messer;R. J. Hollis;R. N. Jones.
Antimicrobial Agents and Chemotherapy (2002)

519 Citations

Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study

D. J. Diekema;S. A. Messer;A. B. Brueggemann;S. L. Coffman.
Journal of Clinical Microbiology (2002)

508 Citations

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

Pfaller;R N Jones;G V Doern;H S Sader.
Antimicrobial Agents and Chemotherapy (2000)

486 Citations

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

M. A. Pfaller;L. Boyken;R. J. Hollis;J. Kroeger.
Journal of Clinical Microbiology (2008)

465 Citations

National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

M.A Pfaller;R.N Jones;S.A Messer;M.B Edmond.
Diagnostic Microbiology and Infectious Disease (1998)

441 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shawn A. Messer

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 133

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 121

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 111

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 111

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 89

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 82

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 77

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 76

Arnaldo Lopes Colombo

Arnaldo Lopes Colombo

Federal University of Sao Paulo

Publications: 76

John R. Perfect

John R. Perfect

Duke University

Publications: 75

Daniel J. Diekema

Daniel J. Diekema

University of Iowa Hospitals and Clinics

Publications: 74

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 71

Luis Ostrosky-Zeichner

Luis Ostrosky-Zeichner

The University of Texas Health Science Center at Houston

Publications: 71

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 71

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 66

Mahmoud A. Ghannoum

Mahmoud A. Ghannoum

Case Western Reserve University

Publications: 65

Something went wrong. Please try again later.